SILVER SPRING, Md., Sept. 27, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Thursday, the FDA updated the Mycotoxins in Domestic […]
Tag: U.S. Food and Drug Administration
FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia
SILVER SPRING, Md., Sept. 26, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults. It is the first […]
FDA Roundup: September 24, 2024
SILVER SPRING, Md., Sept. 24, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA held a ribbon-cutting ceremony to highlight […]
FDA Roundup: September 20, 2024
SILVER SPRING, Md., Sept. 20, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA and NIH announced “Advancing Smoking Cessation: […]
FDA Approves First Treatment for Niemann-Pick Disease, Type C
SILVER SPRING, Md., Sept. 20, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC). Miplyffa, in combination with the enzyme […]
